All Publications

Journal article

The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis.

van der Holt, Bronno Löwenberg, Bob Burnett, Alan K Knauf, Wolfgang U Shepherd, John Piccaluga, Pier Paolo Ossenkoppele, Gert J Verhoef, Gregor E G Ferrant, Augustin[UCL] Crump, Michael Selleslag, Dominik Theobald, Matthias Fey, Martin F Vellenga, Edo Dugan, Margaret Sonneveld, Pieter (2005) Blood — Vol. 106, no. 8, p. 2646-54 (2005)

Journal article

High-dose daunorubicin in older patients with acute myeloid leukemia.

Löwenberg, Bob Ossenkoppele, Gert J. van Putten, Wim Schouten, Harry C. Graux, Carlos Ferrant, Augustin[UCL] Sonneveld, Pieter Maertens, Johan Jongen-Lavrencic, Mojca von Lilienfeld-Toal, Marie Biemond, Bart J. Vellenga, Edo van Marwijk Kooy, Marinus Verdonck, Leo F. Beck, Joachim Döhner, Hartmut Gratwohl, Alois Pabst, Thomas Verhoef, Gregor (2009) New England Journal of Medicine — Vol. 361, no. 13, p. 1235-1248 (2009)

Journal article

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more : results of a multicenter phase 3 study.

Löwenberg, Bob Beck, Joachim Graux, Carlos van Putten, Wim Schouten, Harry C Verdonck, Leo F Ferrant, Augustin Sonneveld, Pieter Jongen-Lavrencic, Mojca von Lilienfeld-Toal, Marie Biemond, Bart J Vellenga, Edo Breems, Dimitri de Muijnck, Hilde Schaafsma, Ron Verhoef, Gregor Döhner, Hartmut Gratwohl, Alois Pabst, Thomas Ossenkoppele, Gert J Maertens, Johan (2010) Blood — Vol. 115, no. 13, p. 2586-2591 (2010)

Journal article

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.

Moreau, Philippe Attal, Michel Hulin, Cyrille Arnulf, Bertrand Belhadj, Karim Benboubker, Lotfi Béné, Marie C Broijl, Annemiek Caillon, Hélène Caillot, Denis Corre, Jill Delforge, Michel Dejoie, Thomas Doyen, Chantal[UCL] Facon, Thierry Sonntag, Cécile Fontan, Jean Garderet, Laurent Jie, Kon-Siong Karlin, Lionel Kuhnowski, Frédérique Lambert, Jérôme Leleu, Xavier Lenain, Pascal Macro, Margaret Mathiot, Claire Orsini-Piocelle, Frédérique Perrot, Aurore Stoppa, Anne-Marie van de Donk, Niels Wcj Wuilleme, Soraya Zweegman, Sonja Kolb, Brigitte Touzeau, Cyrille Roussel, Murielle Tiab, Mourad Marolleau, Jean-Pierre Meuleman, Nathalie Vekemans, Marie-Christiane[UCL] Westerman, Matthijs Klein, Saskia K Levin, Mark-David Fermand, Jean Paul Escoffre-Barbe, Martine Eveillard, Jean-Richard Garidi, Reda Ahmadi, Tahamtan Zhuang, Sen Chiu, Christopher Pei, Lixia de Boer, Carla Smith, Elena Deraedt, William Kampfenkel, Tobias Schecter, Jordan Vermeulen, Jessica Avet-Loiseau, Hervé Sonneveld, Pieter (2019) Lancet — Vol. 394, no. 10192, p. 29-38 (2019)

Journal article

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults.

Daenen, Simon van der Holt, Bronno Verhoef, Gregor E G Löwenberg, Bob Wijermans, Pierre W Huijgens, Peter C van Marwijk Kooy, Rien Schouten, Harry C. Kramer, Mark H H Ferrant, Augustin[UCL] van den Berg, Eva Steijaert, Monique M C Verdonck, Leo F. Sonneveld, Pieter (2004) Leukemia Research : clinical and laboratory studies — Vol. 28, no. 10, p. 1057-1067 (2004)

Journal article

Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial

Moreau, Philippe Hulin, Cyrille Perrot, Aurore Arnulf, Bertrand Belhadj, Karim Benboubker, Lotfi Béné, Marie C Zweegman, Sonja Caillon, Hélène Caillot, Denis Corre, Jill Delforge, Michel Dejoie, Thomas Doyen, Chantal[UCL] Facon, Thierry Sonntag, Cécile Fontan, Jean Mohty, Mohamad Jie, Kon-Siong Karlin, Lionel Kuhnowski, Frédérique Lambert, Jérôme Leleu, Xavier Macro, Margaret Orsini-Piocelle, Frédérique Roussel, Murielle Stoppa, Anne-Marie van de Donk, Niels W C J Wuillème, Soraya Broijl, Annemiek Touzeau, Cyrille Tiab, Mourad Marolleau, Jean-Pierre Meuleman, Nathalie Vekemans, Marie-Christiane[UCL] Westerman, Matthijs Klein, Saskia K Levin, Mark-David Offner, Fritz Escoffre-Barbe, Martine Eveillard, Jean-Richard Garidi, Réda Ahmadi, Tahamtan Krevvata, Maria Zhang, Ke de Boer, Carla Vara, Sanjay Kampfenkel, Tobias Vanquickelberghe, Veronique Vermeulen, Jessica Avet-Loiseau, Hervé Sonneveld, Pieter (2021) The Lancet. Oncology — Vol. 22, no. 10, p. 1378-1390 (2021)

Journal article

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders

Ross, Fiona M Avet-Loiseau, Hervé Ameye, Geneviève[UCL] Gutiérrez, Norma C Liebisch, Peter O'Connor, Sheila Dalva, Klara Fabris, Sonia Testi, Adele M Jarosova, Marie Hodkinson, Clare Collin, Anna Kerndrup, Gitte Kuglik, Petr Ladon, Dariusz Bernasconi, Paolo Maes, Brigitte Zemanova, Zuzana Michalova, Kyra Michaux, Lucienne[UCL] Neben, Kai Hermansen, N Emil U Rack, Katrina Rocci, Alberto Protheroe, Rebecca Chiecchio, Laura Poirel, Hélène[UCL] Sonneveld, Pieter Nyegaard, Mette Johnsen, Hans E the European Myeloma Network (2012) Haematologica : the hematology journal — Vol. 97, no.8, p. 1272-1277 (2012)

Journal article

Cytarabine dose for acute myeloid leukemia.

Löwenberg, Bob Pabst, Thomas Vellenga, Edo van Putten, Wim Schouten, Harry C Graux, Carlos Ferrant, Augustin Sonneveld, Pieter Biemond, Bart J Gratwohl, Alois de Greef, Georgine E Verdonck, Leo F Schaafsma, Martijn R Gregor, Michael Theobald, Matthias Schanz, Urs Maertens, Johan Ossenkoppele, Gert J (2011) The New England journal of medicine — Vol. 364, no. 11, p. 1027-36 (2011)

Journal article

Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.

Sonneveld, Pieter Hajek, Roman Nagler, Arnon Spencer, Andrew Bladé, Joan Robak, Tadeusz Zhuang, Sen H Harousseau, Jean-Luc Orlowski, Robert Z (2008) Cancer — Vol. 112, no.7, p. 1529-37 (2008)

Journal article

Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia

Deenik, Wendy Janssen, Jeroen J.W.M. van der Holt, Bronno Verhoef, Gregor E.G. Smit, Willem M. Kersten, Marie José Daenen, Simon M.G.J. Verdonck, Leo F. Ferrant, Augustin[UCL] Schattenberg, Anton V.M.B. Sonneveld, Pieter van Marwijk Kooy, Marinus Wittebol, Shulamit Willemze, Roelof Wijermans, Pierre W. Beverloo, H. Berna Löwenberg, Bob Valk, Peter J.M. Ossenkoppel, Gert J. Cornelissen, Jan J. (2010) Haematologica : the hematology journal — Vol. 95, no. 6, p. 914-921 (2010)

Journal article

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Stege, Claudia A M Nasserinejad, Kazem van der Spek, Ellen Bilgin, Yavuz M Kentos, Alain Sohne, Maaike van Kampen, Roel J W Ludwig, Inge Thielen, Noortje Durdu-Rayman, Nazik de Graauw, Nicole C H P van de Donk, Niels W C J de Waal, Esther G M Vekemans, Marie-Christiane[UCL] Timmers, Gert Jan van der Klift, Marjolein Soechit, Savita Geerts, Paul A F Silbermann, Matthijs H Oosterveld, Margriet Nijhof, Inger S Sonneveld, Pieter Klein, Saskia K Levin, Mark-David Zweegman, Sonja (2021) Journal of clinical oncology — Vol. 39, no. 25, p. 2758-2767 (2021)

Journal article

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

Löwenberg, Bob van Putten, Wim Theobald, Matthias Gmür, Jurg Verdonck, Leo Sonneveld, Pieter Fey, Martin Schouten, Harry de Greef, Georgine Ferrant, Augustin[UCL] Kovacsovics, Tibor Gratwohl, Alois Daenen, Simon Huijgens, Peter Boogaerts, Marc (2003) The New England journal of medicine — Vol. 349, no. 8, p. 743-52 (2003)

Journal article

Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia

Sonneveld, Pieter Burnett, Alan Vossebeld, Paula Ben-Am, Monique Rosenkranz, Gerd Pfister, Christian Verhoef, Gregor Dekker, Adriaan Ossenkoppele, Gert Ferrant, Claude Yin, Liu Gratwohl, Alois Kovacsovics, Tibor Vellenga, Edo Capdeville, Renaud Löwenberg, Bob (2000) The Hematology Journal — Vol. 1, no. 6, p. 411-421 (2000)

Journal article

Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.

Deenik, Wendy van der Holt, Bronno Verhoef, Gregor E G Smit, Willem M Kersten, Marie J Kluin-Nelemans, Hanneke C Verdonck, Leo F. Ferrant, Augustin[UCL] Schattenberg, Anton V M B Janssen, Jeroen J W M Sonneveld, Pieter van Marwijk Kooy, Marinus Wittebol, Shulamit Willemze, Roelof Wijermans, Pierre W Westveer, Petra H M Beverloo, H Berna Valk, Peter Löwenberg, Bob Ossenkoppele, Gert J Cornelissen, Jan J (2008) Blood — Vol. 111, no. 5, p. 2581-2588 (2008)

Journal article

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.

Groen, Kaz Stege, Claudia A M Nasserinejad, Kazem de Heer, Koen van Kampen, Roel J W Leys, Rineke B L Thielen, Noortje Westerman, Matthijs Wu, Ka-Lung Ludwig, Inge Issa, Djamila E Velders, Gerjo A Vekemans, Marie-Christiane[UCL] Timmers, Gert-Jan de Boer, Fransien Tick, Lidwine W Verbrugge, Annelies Buitenhuis, Danny Cunha, Sonia M van der Spek, Ellen de Waal, Esther G M Sohne, Maaike Sonneveld, Pieter Nijhof, Inger S Klein, Saskia K van de Donk, Niels W C J Levin, Mark-David Ypma, Paula F Zweegman, Sonja (2023) EClinicalMedicine — Vol. 63, p. 102167 [1-12] (2023)

User menu

Current search

Author

Date

Access

Footer Help

Languages

Footer menu